Investigating the Role of DUSP4 in Uveal Melanoma.
Aughton K, Sabat-Pospiech D, Barlow S, Coupland SE, Kalirai H.Transl Vis Sci Technol. 2022 Dec 1;11(12):13.
Aughton K, Sabat-Pospiech D, Barlow S, Coupland SE, Kalirai H.Transl Vis Sci Technol. 2022 Dec 1;11(12):13.
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, Bejar R, Berti E, Busque L, Chan JKC, Chen W, Chen X, Chng WJ, Choi JK, Colmenero I, Coupland SE, ...., Hochhaus A.Leukemia. 2022 Jun 22. doi: 10.1038/s41375-022-01613-1. Online ahead of print.PMID: 35732831
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, Bhagat G, Borges AM, Boyer D, Calaminici M, Chadburn A, Chan JKC, Cheuk W, Chng WJ, Choi JK, Chuang SS, Coupland SE, ......, Xiao W.Leukemia. 2022 Jun 22. doi: 10.1038/s41375-022-01620-2. Online ahead of print.PMID: 35732829
Rola AC, Kalirai H, Taktak AFG, Eleuteri A, Krishna Y, Hussain R, Heimann H, Coupland SE.Cancers (Basel). 2022 Apr 27;14(9):2187. doi: 10.3390/cancers14092187.PMID: 35565316
Jones H, Kalirai H, Taktak A, Chen K, Coupland SE. Vascular Lakes in Uveal Melanoma and Their Association With Outcome. Transl Vis Sci Technol. 2022 Mar 2;11(3):32
Aggressive uveal melanoma displays a high degree of centrosome amplification, opening the door to therapeutic intervention
Sabat-Pośpiech D, Fabian-Kolpanowicz K, Kalirai H, Kipling N, Coupland SE, Coulson JM, Fielding AB.J Pathol Clin Res. 2022 Apr 26. doi: 10.1002/cjp2.272. Online ahead of print.PMID: 35474453
Sabat-Pośpiech D, Fabian-Kolpanowicz K, Kalirai H, Kipling N, Coupland SE, Coulson JM, Fielding AB.J Pathol Clin Res. 2022 Apr 26. doi: 10.1002/cjp2.272. Online ahead of print.PMID: 35474453
Female Presidents of the "Royal College of Pathologists": Their Achievements and Contributions.
Coupland SE, Sandle LN, Osborn M.Front Med (Lausanne). 2022 Apr 6;9:861909. doi: 10.3389/fmed.2022.861909. eCollection 2022.PMID: 35463030 Free PMC article. Review
Coupland SE, Sandle LN, Osborn M.Front Med (Lausanne). 2022 Apr 6;9:861909. doi: 10.3389/fmed.2022.861909. eCollection 2022.PMID: 35463030 Free PMC article. Review
Outcome Measures of New Technologies in Uveal Melanoma: Review from the European Vision Institute Special Interest Focus Group Meeting.
Beenakker JM, Brouwer NJ, Chau C, Coupland SE, Fiorentzis M, Heimann H, Heufelder J, Joussen AM, Kiilgaard JF, Kivelä TT, Piperno-Neumann S, Rantala ES, Romanovska-Dixon B, Shields CL, Willerding GD, Wheeler-Schilling T, Scholl HPN, Jager MJ, Damato BE.Ophthalmic Res. 2022 Mar 31. doi: 10.1159/000524372. Online ahead of print.PMID: 35358966 Free article. Review.
Beenakker JM, Brouwer NJ, Chau C, Coupland SE, Fiorentzis M, Heimann H, Heufelder J, Joussen AM, Kiilgaard JF, Kivelä TT, Piperno-Neumann S, Rantala ES, Romanovska-Dixon B, Shields CL, Willerding GD, Wheeler-Schilling T, Scholl HPN, Jager MJ, Damato BE.Ophthalmic Res. 2022 Mar 31. doi: 10.1159/000524372. Online ahead of print.PMID: 35358966 Free article. Review.
Vest SD, Coupland SE, Esmaeli B, Finger PT, Graue GF, Grossniklaus HE, Hindso TG, Holm F, Honavar SG, Khong JJ, Kirkegaard MK, McKelvie PA, Mikkelsen LH, Mulay K, Rasmussen PK, Siersma V, Sjö LD, Sniegowski MC, Thuro BA, Vemuganti GK, Heegaard S.Br J Ophthalmol. 2022 May 5:bjophthalmol-2021-320466.
